OBJECTIVE: To study the safe and unsafe duration of fasting in children with medium chain acyl-Coenzyme A dehydrogenase (MCAD) deficiency, the literature and the database on Dutch MCAD-deficient patients were searched for data on fasting studies in patients with MCAD deficiency. MATERIALS AND METHODS: These data were extended with information on fasting studies performed on our patients with MCAD deficiency known in the Beatrix Children's Hospital, UMC Groningen, The Netherlands. The data reflect considerable inter-individual variation and overlap between safe and unsafe duration of fasting. RESULTS: In six out of 35 fasting tests, symptoms were reported before hypoglycaemia was observed. Until 1 year of age, the median safe and unsafe duration of fasting was 12 hours (n=7, range 8-19 hours) and 18 hours (n=5, range 15-20 hours), respectively. After the first year of life, the median safe and unsafe duration of fasting was 18 hours (n=17, range 10-24 hours) and 20 hours (n=9, range 13-32 hours), respectively. CONCLUSION: Therefore, to conclude, we recommend a maximum duration of fasting in children with MCAD deficiency of 8 hours between 6 months and 1 year of age, 10 hours in the second year of life and 12 hours thereafter. From this study, no conclusions can be drawn on the duration of fasting during situations of intercurrent illness, especially with fever.
OBJECTIVE: To study the safe and unsafe duration of fasting in children with medium chain acyl-Coenzyme A dehydrogenase (MCAD) deficiency, the literature and the database on Dutch MCAD-deficientpatients were searched for data on fasting studies in patients with MCAD deficiency. MATERIALS AND METHODS: These data were extended with information on fasting studies performed on our patients with MCAD deficiency known in the Beatrix Children's Hospital, UMC Groningen, The Netherlands. The data reflect considerable inter-individual variation and overlap between safe and unsafe duration of fasting. RESULTS: In six out of 35 fasting tests, symptoms were reported before hypoglycaemia was observed. Until 1 year of age, the median safe and unsafe duration of fasting was 12 hours (n=7, range 8-19 hours) and 18 hours (n=5, range 15-20 hours), respectively. After the first year of life, the median safe and unsafe duration of fasting was 18 hours (n=17, range 10-24 hours) and 20 hours (n=9, range 13-32 hours), respectively. CONCLUSION: Therefore, to conclude, we recommend a maximum duration of fasting in children with MCAD deficiency of 8 hours between 6 months and 1 year of age, 10 hours in the second year of life and 12 hours thereafter. From this study, no conclusions can be drawn on the duration of fasting during situations of intercurrent illness, especially with fever.
Authors: J P Bonnefont; N B Specola; A Vassault; A Lombes; H Ogier; J B de Klerk; A Munnich; M Coude; M Paturneau-Jouas; J M Saudubray Journal: Eur J Pediatr Date: 1990-12 Impact factor: 3.183
Authors: Terry G J Derks; Marinus Duran; Hans R Waterham; Dirk-Jan Reijngoud; Leo P Ten Kate; G Peter A Smit Journal: Eur J Hum Genet Date: 2005-08 Impact factor: 4.246
Authors: S E Waisbren; C Y Read; M Ampola; T G Brewster; L Demmer; R Greenstein; C L Ingham; M Korson; M Msall; S Pueschel; M Seashore; V E Shih; H L Levy Journal: J Inherit Metab Dis Date: 2002-11 Impact factor: 4.982
Authors: K Tanaka; I Yokota; P M Coates; A W Strauss; D P Kelly; Z Zhang; N Gregersen; B S Andresen; Y Matsubara; D Curtis Journal: Hum Mutat Date: 1992 Impact factor: 4.878
Authors: M Duran; G Mitchell; J B de Klerk; J P de Jager; M Hofkamp; L Bruinvis; D Ketting; J M Saudubray; S K Wadman Journal: J Pediatr Date: 1985-09 Impact factor: 4.406
Authors: Barbara M Bakker; Karen van Eunen; Jeroen A L Jeneson; Natal A W van Riel; Frank J Bruggeman; Bas Teusink Journal: Biochem Soc Trans Date: 2010-10 Impact factor: 5.407
Authors: Hidde H Huidekoper; Mariëtte T Ackermans; René Koopman; Luc J C van Loon; Hans P Sauerwein; Frits A Wijburg Journal: J Inherit Metab Dis Date: 2012-09-14 Impact factor: 4.982
Authors: Catharina M L Touw; G Peter A Smit; Maaike de Vries; Johannis B C de Klerk; Annet M Bosch; Gepke Visser; Margot F Mulder; M Estela Rubio-Gozalbo; Bert Elvers; Klary E Niezen-Koning; Ronald J A Wanders; Hans R Waterham; Dirk-Jan Reijngoud; Terry G J Derks Journal: Orphanet J Rare Dis Date: 2012-05-25 Impact factor: 4.123
Authors: Anne-Claire M F Martines; Albert Gerding; Sarah Stolle; Marcel A Vieira-Lara; Justina C Wolters; Angelika Jurdzinski; Laura Bongiovanni; Alain de Bruin; Pieter van der Vlies; Gerben van der Vries; Vincent W Bloks; Terry G J Derks; Dirk-Jan Reijngoud; Barbara M Bakker Journal: Sci Rep Date: 2019-10-10 Impact factor: 4.379
Authors: Catharina M L Touw; G Peter A Smit; Klary E Niezen-Koning; Conny Bosgraaf-de Boer; Albert Gerding; Dirk-Jan Reijngoud; Terry G J Derks Journal: Orphanet J Rare Dis Date: 2013-03-20 Impact factor: 4.123